FR2415464A1 - EMBOLISING AND OCCLUSIVE SOLUTION FOR INJECTION, BASED ON PROLAMINE - Google Patents

EMBOLISING AND OCCLUSIVE SOLUTION FOR INJECTION, BASED ON PROLAMINE

Info

Publication number
FR2415464A1
FR2415464A1 FR7902217A FR7902217A FR2415464A1 FR 2415464 A1 FR2415464 A1 FR 2415464A1 FR 7902217 A FR7902217 A FR 7902217A FR 7902217 A FR7902217 A FR 7902217A FR 2415464 A1 FR2415464 A1 FR 2415464A1
Authority
FR
France
Prior art keywords
prolamine
injection
solution
embolising
occlusive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7902217A
Other languages
French (fr)
Other versions
FR2415464B1 (en
Inventor
Herman Dahlke
Hans Muxfeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of FR2415464A1 publication Critical patent/FR2415464A1/en
Application granted granted Critical
Publication of FR2415464B1 publication Critical patent/FR2415464B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

L'invention concerne une solution injectable permettant de réaliser l'embolisation et l'occlusion d'organes du corps humain et de leurs systèmes circulatoires sans apparition d'effets secondaires. La solution contient une prolamine (de préférence de la zéine) dans un solvant physiologiquement compatible ainsi qu'une émulsion d'huile physiologiquement compatible, et divers produits tels que : substances radioactives, agents cytostatiques, substances antimicrobiennes, et un agent de contraste avec les rayons X pour faciliter la surveillance de l'injection, ainsi qu'éventuellement un inhibiteur pancréatique.The invention relates to an injectable solution for carrying out the embolization and occlusion of organs of the human body and their circulatory systems without the occurrence of side effects. The solution contains prolamine (preferably zein) in a physiologically compatible solvent as well as a physiologically compatible oil emulsion, and various products such as: radioactive substances, cytostatic agents, antimicrobial substances, and a contrast agent with the X-rays to facilitate monitoring of the injection, as well as possibly a pancreatic inhibitor.

FR7902217A 1978-01-30 1979-01-29 EMBOLISING AND OCCLUSIVE SOLUTION FOR INJECTION, BASED ON PROLAMINE Granted FR2415464A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2803869A DE2803869C2 (en) 1978-01-30 1978-01-30 Injectable embolization and occlusion solution

Publications (2)

Publication Number Publication Date
FR2415464A1 true FR2415464A1 (en) 1979-08-24
FR2415464B1 FR2415464B1 (en) 1983-07-01

Family

ID=6030689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7902217A Granted FR2415464A1 (en) 1978-01-30 1979-01-29 EMBOLISING AND OCCLUSIVE SOLUTION FOR INJECTION, BASED ON PROLAMINE

Country Status (8)

Country Link
JP (1) JPS54123281A (en)
AT (1) AT363599B (en)
AU (1) AU525929B2 (en)
CA (1) CA1116088A (en)
DE (1) DE2803869C2 (en)
FR (1) FR2415464A1 (en)
GB (1) GB2014043B (en)
NL (1) NL191433C (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115549B1 (en) * 1983-02-03 1987-11-25 Ethicon, Inc. Paste for hemostasis and for temporary relief of defects in the traumatism of bones
EP0128578A1 (en) * 1983-06-14 1984-12-19 Byk Gulden Lomberg Chemische Fabrik GmbH Ethanolic suspensions of contrast agents
CA1225585A (en) * 1983-06-30 1987-08-18 Maria T. Litvinova Composition for embolization of blood vessels
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
US6180113B1 (en) 1996-02-23 2001-01-30 Schering Ag Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes
DE19608278A1 (en) * 1996-02-23 1997-08-28 Schering Ag Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology
KR970069028A (en) * 1996-04-01 1997-11-07 김은영 Manufacturing method of chemical color exclusive emulsion
US6333020B1 (en) * 1999-05-13 2001-12-25 Micro Therapeutics, Inc. Methods for treating AVM's using radio active compositions
DE10261694A1 (en) * 2002-12-30 2004-07-15 Brassel, Friedhelm, Prof. Dr.med. Liquid embolism
CH712511B1 (en) * 2006-09-18 2017-11-30 Forim-X Ag C/O Prof Dr Med Richard Dirnhofer X-ray contrast media for postmortem, experimental and diagnostic angiography.
ES2530718T3 (en) * 2006-09-18 2015-03-04 Forim X Ag X-ray contrast agent for postmortem, experimental and diagnostic angiography
CN107935870A (en) * 2017-11-09 2018-04-20 华中药业股份有限公司 A kind of synthetic method of 2 methylamino, 5 chlorobenzophenone
CN113813392A (en) * 2021-10-23 2021-12-21 哈尔滨工业大学 Preparation method of blood cell-like drug carrier

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052951A1 (en) * 1969-06-11 1971-04-16 Sterling Drug Inc

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB311382A (en) * 1928-05-10 1930-08-07 H A Metz Lab Inc Improvements in or relating to the manufacture of spinal anaesthetic solutions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052951A1 (en) * 1969-06-11 1971-04-16 Sterling Drug Inc

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1978 *

Also Published As

Publication number Publication date
JPS54123281A (en) 1979-09-25
DE2803869A1 (en) 1979-08-02
NL191433C (en) 1995-07-04
CA1116088A (en) 1982-01-12
ATA65679A (en) 1981-01-15
AT363599B (en) 1981-08-10
JPH0129774B2 (en) 1989-06-14
AU4343079A (en) 1979-08-09
DE2803869C2 (en) 1983-12-29
NL191433B (en) 1995-03-01
AU525929B2 (en) 1982-12-09
GB2014043B (en) 1982-08-11
GB2014043A (en) 1979-08-22
FR2415464B1 (en) 1983-07-01
NL7900649A (en) 1979-08-01

Similar Documents

Publication Publication Date Title
FR2415464A1 (en) EMBOLISING AND OCCLUSIVE SOLUTION FOR INJECTION, BASED ON PROLAMINE
DE69433478T2 (en) USE OF STAINOXIDE ADDUCTS TO PREVENT THROMBOSES ON ARTIFICIAL AND VASCULAR SURFACES
Essed et al. Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.
Adams et al. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo
DE69939685D1 (en) DEVICE FOR INTRAVASCULAR EMBOLIZATION
ES2074406T1 (en) ELECTROLYTICALLY ENDOVASCULAR REMOVABLE PILOT WIRE TIP.
FR2401662A1 (en) PRESSURE ADHESIVE COMPOSITIONS
ES2052881T3 (en) BLOOD PRESSURE REDUCING AGENTS.
ES520602A0 (en) PROCEDURE FOR THE TREATMENT OF LIQUID FOODS THAT HAVE OXYGEN DISSOLVED OR OCCLUDED.
ES510245A0 (en) "A METHOD TO OBTAIN AN INSULIN PREPARATION".
AR027748A1 (en) SMALL SPHERES OR BALLOONS THAT CONTAIN STAVUDINE AND ALLOW THE CONTROLLED RELEASE OF THE SAME
KR950703527A (en) Prostaglandin derivatives
MX9206336A (en) METHOD FOR PRESERVATION OF AN EX LIVING ORGAN.
DK155073C (en) SOCIAL DISINFECTANT
Mikhail et al. Observations on the mode of termination and parenchymal distribution of the splenic artery with evidence of splenic lobation and segmentation.
GB1353635A (en) Coating composition for moist surfaces
Fisher et al. Continued sac expansion in the absence of a demonstrable endoleak is an indication for secondary intervention
NO891220D0 (en) COMPOSITION CONTAINING SALICYLIC ACID FOR TREATING LEPIDOSE.
BR9914834A (en) Bone pathobolism treatment agent, and, method to intensify the activity of osteoclastogenesis inhibiting factor
FR2773712B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE AMINOPEPTIDASE A INHIBITOR
KR930012009A (en) How to prevent reclosure of arteries
FR2456474A1 (en) MAINTENANCE AGENT THAT CAN BE SPRAYED FROM A CONTAINER, AND METHOD FOR MAINTAINING MEDICAL INSTRUMENTS, ESPECIALLY DENTISTRY WITH SUCH AN AGENT
Gottlob et al. The toxic action of alkylcyanoacrylate adhesives on vessels: comparative studies
MX9302924A (en) CATARACT TREATMENT AGENT AND METHOD FOR ITS PREPARATION.
KIEHN et al. Study of revascularization of blood vessel grafts by means of radioactive phosphorus